NCT01002846

Brief Summary

This is randomised, controlled study about effects of acupuncture on blood pressure and endothelial dysfunction in stage I hypertension patient without medication. Subject will receive 8 weeks of either acupuncture or sham acupuncture, measuring FMD and blood test before and after treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
32

participants targeted

Target at below P25 for phase_3 hypertension

Timeline
Completed

Started Sep 2009

Shorter than P25 for phase_3 hypertension

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2009

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 26, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 27, 2009

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2010

Completed
Last Updated

October 27, 2009

Status Verified

October 1, 2009

Enrollment Period

9 months

First QC Date

October 26, 2009

Last Update Submit

October 26, 2009

Conditions

Keywords

EfficacyAcupunctureHypertension

Outcome Measures

Primary Outcomes (1)

  • To assess effects of acupuncture on endothelial function with FMD variation after 8 weeks treatments.

    8 weeks

Secondary Outcomes (1)

  • To examine the effects of acupuncture on blood pressure, lipid , hsCRP level variation with ABPM after 8 weeks treatments.

    8 weeks

Study Arms (2)

traditional acupuncture

EXPERIMENTAL

Procedure : ST 36 and PC 6 are selected, subject will undergo 20minute sessions twice a week for 8weeks. Disposable acupuncture needle(4cm sterilized stainless steel) will be inserted up to 1 cm depth

Procedure: acupuncture

sham acupuncture

SHAM COMPARATOR

Procedure : Beside 1cm of ST 36 and PC 6 are selected( not meridian point), subject will undergo 20 minute. Disposable acupuncture needle(4cm sterilized stainless steel) will be inserted under 1 cm slightly.

Procedure: acupuncture

Interventions

acupuncturePROCEDURE

acupuncture group : subject will undergo 20minute sessions twice a week for 8weeks. Disposable acupuncture needle(4cm sterilized stainless steel) will be inserted up to 1 cm depth sham acupuncture group : subject will undergo 20 minute. Disposable acupuncture needle(4cm sterilized stainless steel) will be inserted under 1 cm slightly.

sham acupuncturetraditional acupuncture

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients age 18-70 diagnosed stage I hypertension ( JNC-7) without taking hypertensive medication

You may not qualify if:

  • Secondary hypertension
  • History of cardiovascular disease
  • Taking hypertensive medication
  • Taking hyperlipidemic medication
  • Smoking
  • Pregnancy or feeding woman
  • Cannot follow indication or there is no agreement of patient and conservator
  • Investigator decide Inappropriate to trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oriental Medicine of Stroke and Nerologic center

Seoul, South Korea, South Korea

RECRUITING

MeSH Terms

Conditions

Hypertension

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • SeongUk Park, OMD

    Oriental medicine center of Stroke and Neurology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 26, 2009

First Posted

October 27, 2009

Study Start

September 1, 2009

Primary Completion

June 1, 2010

Study Completion

June 1, 2010

Last Updated

October 27, 2009

Record last verified: 2009-10

Locations